Amgen (AMGN)
(Delayed Data from NSDQ)
$334.30 USD
-1.31 (-0.39%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $336.00 +1.70 (0.51%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth B Momentum D VGM
Price, Consensus and EPS Surprise
AMGN 334.30 -1.31(-0.39%)
Will AMGN be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for AMGN based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for AMGN
Amgen (AMGN) Stock Moves -0.39%: What You Should Know
AstraZeneca (AZN) Beats on Q2 Earnings & Sales, Ups '24 View
AMGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
What Lies in Store for Healthcare ETFs in Q2 Earnings?
Is a Beat in the Cards for Incyte (INCY) in Q2 Earnings?
What's in Store for Structure Therapeutics (GPCR) in Q2 Earnings?
Other News for AMGN
Market Whales and Their Recent Bets on AMGN Options
September 6th Options Now Available For Amgen (AMGN)
Viking sends Lilly, Novo lower as obesity drug enters late-stage program
HRTS: Generating Alpha In Obesity Treatment
3 Fabulous Growth Stocks to Buy and Hold Forever